Many new drug candidates are poorly soluble and require solubilization technologies to meet bioperformance targets. Amorphous solid dispersions (ASDs) are a popular way to increase solubility and absorption. The presentation will discuss how to identify a drug as a good candidate for an amorphous solid dispersion, define the specific problem statement for absorption, and design of the ideal ASD to address the problem statement. In addition, there will be a discussion on considerations for scale up and dose form development. <br/><br/>

Designing successful amorphous solid dispersions

2019 Fall National Meeting

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.